Steward Partners Investment Advisory’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.47M Buy
2025
Q2
$2.24M Buy
2025
Q1
$610K Buy
2024
Q4
$401K Buy
2024
Q3
$375K Buy
2024
Q2
$10.2K Sell
2024
Q1
$13.3K Hold
2023
Q4
$7.12K Hold
2023
Q3
$4.91K Hold
2023
Q2
$8.71K Buy
2023
Q1
$7.81K Buy